
Dual GIP/GLP-1 receptor agonist studied in metabolic research.

Semaglutide is a GLP-1 receptor agonist. Research examines glucose regulation, appetite signaling, gastric emptying, and weight-related metabolic measures.
Semaglutide is a long-acting GLP-1 analog with a substantial body of published clinical research. The product sold here is for laboratory research only.
Clinical and laboratory studies use different schedules, concentrations, and handling procedures. Use the primary study and your institution’s procedures for the exact setup.
These notes are a starting point, not a laboratory protocol or medical guidance. Check the primary sources, your institution’s procedures, and applicable regulations before planning any work.